COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines"
- PMID: 34128563
- PMCID: PMC8441644
- DOI: 10.1111/all.14761
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines"
Conflict of interest statement
Figures

Comment on
-
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines.Allergy. 2021 Jun;76(6):1941-1942. doi: 10.1111/all.14774. Allergy. 2021. PMID: 34128559 Free PMC article. No abstract available.
Similar articles
-
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines.Allergy. 2021 Jun;76(6):1941-1942. doi: 10.1111/all.14774. Allergy. 2021. PMID: 34128559 Free PMC article. No abstract available.
-
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.Vaccine. 2023 Jul 19;41(32):4693-4699. doi: 10.1016/j.vaccine.2023.06.039. Epub 2023 Jun 15. Vaccine. 2023. PMID: 37349223 Free PMC article.
-
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2. J Investig Allergol Clin Immunol. 2021. PMID: 33648905 Clinical Trial. No abstract available.
-
Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.Acta Med Port. 2021 Jun 30;34(7-8):541-547. doi: 10.20344/amp.16096. Epub 2021 May 21. Acta Med Port. 2021. PMID: 34851819 Review.
-
Allergy to COVID-19 vaccines: A current update.Allergol Int. 2021 Jul;70(3):313-318. doi: 10.1016/j.alit.2021.04.003. Epub 2021 Apr 23. Allergol Int. 2021. PMID: 33962863 Free PMC article. Review.
Cited by
-
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.Vaccines (Basel). 2021 Aug 25;9(9):944. doi: 10.3390/vaccines9090944. Vaccines (Basel). 2021. PMID: 34579181 Free PMC article. Review.
-
SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?Rev Saude Publica. 2021 Oct 29;55:70. doi: 10.11606/s1518-8787.2021055003855. eCollection 2021. Rev Saude Publica. 2021. PMID: 34730750 Free PMC article.
-
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.Biomedicines. 2022 May 28;10(6):1260. doi: 10.3390/biomedicines10061260. Biomedicines. 2022. PMID: 35740283 Free PMC article. Review.
-
Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China.Front Immunol. 2022 Sep 5;13:882919. doi: 10.3389/fimmu.2022.882919. eCollection 2022. Front Immunol. 2022. PMID: 36131922 Free PMC article.
-
Recent advances and developments in COVID-19 in the context of allergic diseases.Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065. Clin Transl Allergy. 2021. PMID: 34582102 Free PMC article.
References
-
- Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID‐19 vaccine: a potential role for polyethylene glycol?. Allergy 2021;76(6):1617‐1618. - PubMed
-
- Lukawska J, Mandaliya D, Chan AWE, et al. Anaphylaxis to trometamol excipient in gadolinium‐based contrast agents for clinical imaging. J Allergy Clin Immunol Pract. 2019;7(3):1086‐1087. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical